DBT Skills Training for Lung Cancer
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to determine if a therapy called LiveWell, which uses adapted Dialectical Behavioral Therapy (DBT) Skills Training, can improve the quality of life for individuals with advanced lung cancer. The therapy teaches skills such as mindfulness, emotion regulation, and effective communication to help manage stress and symptoms like pain and fatigue. Delivered in eight one-on-one video sessions, it provides support without requiring travel. This trial may suit those with stage IV non-small cell lung cancer who experience significant distress. Participants should currently be undergoing cancer treatment. As an unphased trial, this study offers an opportunity to explore innovative therapies that could enhance quality of life.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It seems focused on psychological skills training, so it's unlikely to require changes to your medication, but you should confirm with the trial coordinators.
What prior data suggests that this DBT Skills Training protocol is safe for patients with metastatic lung cancer?
Research has shown that Dialectical Behavioral Therapy (DBT) Skills Training is generally safe and well-tolerated by patients. In past studies, patients with advanced lung cancer who participated in DBT Skills Training reported very few negative effects. This therapy teaches practical skills to help manage emotions and stress, which can improve mental health.
DBT Skills Training has been used in various settings and with different groups, consistently demonstrating its safety. Unlike medication, it doesn't cause physical side effects. Instead, it helps patients address emotional challenges. Participants learn skills like mindfulness (staying present), distress tolerance (handling difficult emotions), emotion regulation (managing feelings), and interpersonal effectiveness (communicating well with others), which may help reduce anxiety and depression.
LiveWell, the version of DBT adapted for advanced lung cancer, is based on this well-established therapy and is expected to be safe. However, it is always important to monitor how one feels during any treatment and discuss it with healthcare providers.12345Why are researchers excited about this trial?
Researchers are excited about LiveWell: Adapted DBT Skills Training because it offers a fresh approach to supporting patients with metastatic lung cancer. Unlike traditional treatments that focus primarily on the physical aspects of cancer, LiveWell emphasizes mental and emotional well-being through Dialectical Behavioral Therapy (DBT). This intervention teaches patients mindfulness, emotion regulation, distress tolerance, and interpersonal effectiveness, all delivered via convenient telehealth sessions. By focusing on coping skills and emotional health, LiveWell aims to improve quality of life and help patients manage the challenges of living with metastatic cancer.
What evidence suggests that LiveWell: Adapted DBT Skills Training is effective for metastatic lung cancer?
Research has shown that Dialectical Behavioral Therapy (DBT) Skills Training can improve mental health by teaching ways to manage emotions and stress. Studies have found DBT effective in reducing anxiety, depression, and distress in various patient groups. In this trial, participants will receive the LiveWell program, which tailors DBT specifically for patients with metastatic lung cancer. It focuses on skills like mindfulness, managing emotions, and handling distress, helping patients cope with the emotional and physical challenges of their condition. Early results suggest these skills may enhance the quality of life for those with metastatic lung cancer.12367
Who Is on the Research Team?
Tamara Somers
Principal Investigator
Professor in Psychiatry and Behavioral Sciences
Are You a Good Fit for This Trial?
This trial is for adults over 18 with stage IV non-small cell lung cancer, currently undergoing treatment without the aim of cure. Participants must experience distress levels of at least 3 out of 10 and be able to understand and communicate in English.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Intervention Refinement
Iterative refinement of the LiveWell protocol using qualitative exit interview data, advisory board input, and user testing
Treatment
Participants receive the LiveWell intervention, an 8-session Dialectical Behavioral Therapy Skills Training protocol delivered via videoconference
Follow-up
Participants are monitored for changes in quality of life, psychological distress, and symptom burden
What Are the Treatments Tested in This Trial?
Interventions
- LiveWell: Adapted DBT Skills Training
Find a Clinic Near You
Who Is Running the Clinical Trial?
Duke University
Lead Sponsor
National Cancer Institute (NCI)
Collaborator